Do analysts rate GRML or VRCA?

Verrica Pharmaceuticals has a consensus price target of $14.50, indicating a potential upside of 188.84%. Given Verrica Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Verrica Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Verrica Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts rate GRML or ICCC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 ImmuCell 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor GRML or ICCC?

In the previous week, ImmuCell had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 5 mentions for ImmuCell and 4 mentions for Greenland Mines Ltd. Common Stock. ImmuCell's average media sentiment score of 1.08 beat Greenland Mines Ltd. Common Stock's score of 0.87 indicating that ImmuCell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ImmuCell 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer GRML or ENLV?

Enlivex Therapeutics has a consensus price target of $247.50, indicating a potential upside of 5,792.86%. Given Enlivex Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Enlivex Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Enlivex Therapeutics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, GRML or ENLV?

Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Enlivex Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A Enlivex Therapeutics N/A N/A $1.24B -$8.25 N/A

Is GRML or ENLV more profitable?

Enlivex Therapeutics' return on equity of 248.08% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Enlivex Therapeutics N/A 248.08% 206.39%

Do analysts rate GRML or SPRO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Spero Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer GRML or SPRO?

In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Spero Therapeutics. MarketBeat recorded 4 mentions for Greenland Mines Ltd. Common Stock and 3 mentions for Spero Therapeutics. Spero Therapeutics' average media sentiment score of 0.93 beat Greenland Mines Ltd. Common Stock's score of 0.87 indicating that Spero Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spero Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate GRML or AADI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aadi Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media prefer GRML or AADI?

In the previous week, Greenland Mines Ltd. Common Stock had 3 more articles in the media than Aadi Bioscience. MarketBeat recorded 4 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for Aadi Bioscience. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.87 beat Aadi Bioscience's score of -0.71 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aadi Bioscience 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

Greenland Mines Ltd. Common Stock (GRML) Competitors

$0.19 -0.01 (-3.94%)

As of 07/24/2026 04:00 PM Eastern

Compare

GRML vs. VRCA, ICCC, ENLV, SPRO, and AADI

Should you buy Greenland Mines Ltd. Common Stock stock or one of its competitors? MarketBeat compares Greenland Mines Ltd. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Greenland Mines Ltd. Common Stock include Verrica Pharmaceuticals (VRCA), ImmuCell (ICCC), Enlivex Therapeutics (ENLV), Spero Therapeutics (SPRO), and Aadi Bioscience (AADI). These companies are all part of the "pharmaceutical products" industry.

How does Greenland Mines Ltd. Common Stock compare to Verrica Pharmaceuticals?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Verrica Pharmaceuticals (NASDAQ:VRCA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Verrica Pharmaceuticals' net margin of -47.97%. Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Verrica Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Verrica Pharmaceuticals	-47.97%	-1,077.78%	-40.76%

20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 42.5% of Verrica Pharmaceuticals shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Comparatively, 54.0% of Verrica Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its stock price is 605% more volatile than the broader market. Comparatively, Verrica Pharmaceuticals has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

Verrica Pharmaceuticals has a consensus price target of $14.50, indicating a potential upside of 188.84%. Given Verrica Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Verrica Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Verrica Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Verrica Pharmaceuticals. Verrica Pharmaceuticals is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Verrica Pharmaceuticals	$37.16M	2.32	-$17.89M	-$1.03	N/A

In the previous week, Verrica Pharmaceuticals had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 5 mentions for Verrica Pharmaceuticals and 4 mentions for Greenland Mines Ltd. Common Stock. Verrica Pharmaceuticals' average media sentiment score of 1.01 beat Greenland Mines Ltd. Common Stock's score of 0.87 indicating that Verrica Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Verrica Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Verrica Pharmaceuticals beats Greenland Mines Ltd. Common Stock on 9 of the 15 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to ImmuCell?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and ImmuCell (NASDAQ:ICCC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ImmuCell	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its stock price is 605% more volatile than the broader market. Comparatively, ImmuCell has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

In the previous week, ImmuCell had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 5 mentions for ImmuCell and 4 mentions for Greenland Mines Ltd. Common Stock. ImmuCell's average media sentiment score of 1.08 beat Greenland Mines Ltd. Common Stock's score of 0.87 indicating that ImmuCell is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ImmuCell	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 13.5% of ImmuCell shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 5.7% of ImmuCell shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

ImmuCell has higher revenue and earnings than Greenland Mines Ltd. Common Stock. ImmuCell is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
ImmuCell	$27.64M	3.61	-$1.04M	-$0.06	N/A

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to ImmuCell's net margin of -1.82%. ImmuCell's return on equity of -1.88% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
ImmuCell	-1.82%	-1.88%	-1.22%

Summary

ImmuCell beats Greenland Mines Ltd. Common Stock on 7 of the 12 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Enlivex Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Enlivex Therapeutics (NASDAQ:ENLV) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, Enlivex Therapeutics had 4 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 8 mentions for Enlivex Therapeutics and 4 mentions for Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.87 beat Enlivex Therapeutics' score of 0.78 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enlivex Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 1.0% of Enlivex Therapeutics shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Comparatively, 12.3% of Enlivex Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Enlivex Therapeutics' return on equity of 248.08% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Enlivex Therapeutics	N/A	248.08%	206.39%

Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its share price is 605% more volatile than the broader market. Comparatively, Enlivex Therapeutics has a beta of 1.52, meaning that its share price is 52% more volatile than the broader market.

Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Enlivex Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Enlivex Therapeutics	N/A	N/A	$1.24B	-$8.25	N/A

Enlivex Therapeutics has a consensus price target of $247.50, indicating a potential upside of 5,792.86%. Given Enlivex Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Enlivex Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Enlivex Therapeutics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Enlivex Therapeutics beats Greenland Mines Ltd. Common Stock on 10 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Spero Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Spero Therapeutics (NASDAQ:SPRO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its stock price is 605% more volatile than the broader market. Comparatively, Spero Therapeutics has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Spero Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 25.6% of Spero Therapeutics shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Comparatively, 2.9% of Spero Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Spero Therapeutics. MarketBeat recorded 4 mentions for Greenland Mines Ltd. Common Stock and 3 mentions for Spero Therapeutics. Spero Therapeutics' average media sentiment score of 0.93 beat Greenland Mines Ltd. Common Stock's score of 0.87 indicating that Spero Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spero Therapeutics	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Spero Therapeutics has higher revenue and earnings than Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Spero Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Spero Therapeutics	$66.80M	1.03	$8.57M	$0.24	4.96

Spero Therapeutics has a net margin of 24.90% compared to Greenland Mines Ltd. Common Stock's net margin of 0.00%. Spero Therapeutics' return on equity of 35.58% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Spero Therapeutics	24.90%	35.58%	24.95%

Summary

Spero Therapeutics beats Greenland Mines Ltd. Common Stock on 10 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Aadi Bioscience?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its share price is 605% more volatile than the broader market. Comparatively, Aadi Bioscience has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

In the previous week, Greenland Mines Ltd. Common Stock had 3 more articles in the media than Aadi Bioscience. MarketBeat recorded 4 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for Aadi Bioscience. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.87 beat Aadi Bioscience's score of -0.71 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aadi Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Aadi Bioscience	$25.07M	3.65	-$65.76M	-$2.35	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aadi Bioscience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Aadi Bioscience	-246.06%	-71.87%	-57.28%

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 37.3% of Aadi Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Greenland Mines Ltd. Common Stock beats Aadi Bioscience on 8 of the 13 factors compared between the two stocks.

Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRML vs. The Competition

Export

Metric	Greenland Mines Ltd. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$26.60M	$3.07B	$6.87B	$12.26B
Dividend Yield	N/A	2.07%	2.67%	9.79%
P/E Ratio	-0.60	20.29	27.14	23.64
Price / Sales	N/A	485.19	517.08	89.45
Price / Cash	N/A	27.62	50.54	59.64
Price / Book	1.48	4.13	10.28	6.07
Net Income	-$10.55M	$65.94M	$3.60B	$331.99M
7 Day Performance	-7.89%	-4.16%	-1.27%	-0.63%
1 Month Performance	-8.29%	-3.76%	-0.37%	-2.00%
1 Year Performance	-84.34%	9.94%	18.30%	13.62%

Greenland Mines Ltd. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRML Greenland Mines Ltd. Common Stock	0.3232 of 5 stars	$0.19 -3.9%	N/A	-84.8%	$26.60M	N/A	N/A	5	News Coverage Gap Up
VRCA Verrica Pharmaceuticals	2.7827 of 5 stars	$5.76 -2.8%	$14.50 +151.6%	-28.3%	$99.46M	$35.58M	N/A	40	News Coverage Positive News Analyst Downgrade
ICCC ImmuCell	1.5618 of 5 stars	$10.94 -6.6%	N/A	+63.2%	$99.02M	$27.64M	N/A	70
ENLV Enlivex Therapeutics	3.1993 of 5 stars	$5.79 -4.2%	$247.50 +4,171.7%	-75.5%	$97.08M	N/A	N/A	70	News Coverage Analyst Upgrade Short Interest Decrease
SPRO Spero Therapeutics	1.6493 of 5 stars	$1.68 -1.5%	N/A	-49.4%	$96.98M	$66.80M	6.98	150	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GRML) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. VRCA, ICCC, ENLV, SPRO, and AADI

How does Greenland Mines Ltd. Common Stock compare to Verrica Pharmaceuticals?

Summary

How does Greenland Mines Ltd. Common Stock compare to ImmuCell?

Summary

How does Greenland Mines Ltd. Common Stock compare to Enlivex Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spero Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Aadi Bioscience?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. VRCA, ICCC, ENLV, SPRO, and AADI

How does Greenland Mines Ltd. Common Stock compare to Verrica Pharmaceuticals?

Is GRML or VRCA more profitable?

Do insiders and institutionals believe in GRML or VRCA?

Which has more risk and volatility, GRML or VRCA?

Do analysts rate GRML or VRCA?

Which has preferable earnings and valuation, GRML or VRCA?

Does the media favor GRML or VRCA?

Summary

How does Greenland Mines Ltd. Common Stock compare to ImmuCell?

Do analysts rate GRML or ICCC?

Which has more risk and volatility, GRML or ICCC?

Does the media favor GRML or ICCC?

Do insiders and institutionals have more ownership in GRML or ICCC?

Which has higher valuation and earnings, GRML or ICCC?

Is GRML or ICCC more profitable?

Summary

How does Greenland Mines Ltd. Common Stock compare to Enlivex Therapeutics?

Does the media prefer GRML or ENLV?

Do insiders & institutionals have more ownership in GRML or ENLV?

Is GRML or ENLV more profitable?

Which has more risk and volatility, GRML or ENLV?

Which has stronger earnings & valuation, GRML or ENLV?

Do analysts prefer GRML or ENLV?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spero Therapeutics?

Which has more risk & volatility, GRML or SPRO?

Do analysts rate GRML or SPRO?

Do institutionals & insiders hold more shares of GRML or SPRO?

Does the media prefer GRML or SPRO?

Which has higher earnings & valuation, GRML or SPRO?

Is GRML or SPRO more profitable?

Summary

How does Greenland Mines Ltd. Common Stock compare to Aadi Bioscience?

Which has more volatility & risk, GRML or AADI?

Does the media prefer GRML or AADI?

Which has preferable valuation & earnings, GRML or AADI?

Do analysts rate GRML or AADI?

Is GRML or AADI more profitable?

Do insiders & institutionals hold more shares of GRML or AADI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools